In Brief: Venisect
This article was originally published in The Gray Sheet
Executive Summary
Venisect: Plans to begin sales of its Laser Lancet in 60 days after receiving 510(k) clearance from FDA on April 11 for the device, which uses a laser pulse to draw blood samples. The Little Rock, Arkansas-based firm submitted the 510(k) in December 1995 ("The Gray Sheet" Feb. 5, 1996, I&W-6). St. Louis-based LaBarge, which jointly developed the device with Venisect, holds exclusive manufacturing rights...